Question

Depression is a common disease among young and older adults. Although it can be treated, non-adherence is very common among individuals of different ages. The aim of the present paper is to review and summarize research findings regarding depression among young and older adults, with a special focus on the phenomenon of treatment non-adherence among young and older adults with depression. The first section of the review focuses on describing the characteristics of depression in young and older adults. The second section focuses on treatment non-adherence of young and older adults, the prevalence of this phenomenon, and its consequences. The third section focuses on several factors (illness beliefs, treatment beliefs, self-stigma, and self-esteem) that were identified as having a significant association with treatment non-adherence of individuals with depression, with special attention focused on age differences. Results of the review of the literature reveal that research in the area of depression treatment non-adherence and its predictors among young and older adults has received, to date, very minor and limited attention. Thus, there is a need to expand the current body of knowledge and promote future interventions geared towards the unique characteristics of depression among young and older adults, in order to increase their treatment adherence.

BACKGROUND:

Research has shown that lack of treatment adherence is a serious problem, especially among patients with psychiatric disorders. The current study was conducted to assess adherence and patient preference among individuals taking Wellbutrin SR (bupropion) for depression, as well as their interest in a once-daily formulation of bupropion.

METHODS:

A 20-item web-based survey was administered to 527 individuals (276 men and 251 women) recruited through an online panel. All participants were at least 18 years of age, diagnosed with major depressive disorder, and had been taking Wellbutrin SR for at least 6 weeks. Survey items addressed treatment regimen, adherence, satisfaction with Wellbutrin SR, and interest in a once-daily formulation of bupropion.

RESULTS:

The majority of respondents reported taking Wellbutrin SR twice a day (67%). Only 15% of once-daily users were nonadherent compared to 37% of twice-daily users and 65% of thrice-daily users. The most common reason reported for missing a dose of Wellbutrin SR was simply forgetting to take it (49% of twice-daily users and 65% of thrice-daily users). Results indicated that 77% of twice-daily users and 94% of thrice-daily users were interested in a once-daily formula.

CONCLUSIONS:

A reduction in dosing frequency is favored by Wellbutrin SR users and likely to improve their adherence to treatment. Because greater adherence has been shown to facilitate symptom relief, improvements in quality of life, and reductions in healthcare expenses, the results of this study support the value of the recently released once-daily formulation, Wellbutrin XL.

Questions

1

Develop several strategies that you believe will improve medication compliance by patients. (200 no plagiarism please no bullet points)

2

Design your "new educational intervention on improving medication adherence for depressed patients, outcome measures...:(400 no plagiarism please no bullet points)

Answer 1

1, Patient with their chronic conditions need strict adherence with medications to avoid high risk. Failure to medication regimen adherence leads to adverse reactions and death. Several strategies help patients adherence to medications.
-educate the patient about the importance of medication and remain adherence to drug therapy, make them get assured that medication. it provides a positive impact on their well being.
-Make interaction with patients and allow for an open talk about a patient concern before starting the drug therapy it improves trust between providers and patient.
-Involve them with independent pharmacies to interact with the person and increase their relationship.
-engage the staff in caring for the patient. web-based tools help patient and team to engage, their brief talk help patient and staffs to find the nonadherence and request for a refill.
-Monitor and track patient adherence by implementing tools and allow pharmacy people to target patients to adherence to medications.
-Help patients to customize their adherence by following up and making course adjustments in a simple daily pillbox.
-Make an appointment to visit doctors and pharmacies for correct workflow and patient experience.
-coordinate medication refills at the same time every month.
-A comprehensive medication review by pharmacists provides additional medication adherence for the patient.
2, Multicomponent strategy for improving medication adherence for the depressed patient by educational intervention need collaborative care and reminder system through a mobile app like mobile phones, telehealth, and electronic pill dispenser. medication adherence important for depressed patients to avoid complications. A web-based psychoeducational program by using electronic pill monitoring encourages them to make adherence. psychoeducation includes motivational enhancement on medication adherence, educational topics for disease, symptoms management, warning signs, medication action, use, potential barriers for adherence. Education for depressed patients provides multicomponent intervention through videoconference. Medication adherence for depressed patients should include psychiatric health care including cognitive behavioral therapy, symptoms review, and medication adherence counseling. education intervention provides information and helps for addressing perceptual nonadherence factors with social support.